Thymulin
A thymus hormone for an immune system running weak with age, in short zinc-paired courses. Nothing you feel; count the colds you skip.
What it is
Thymulin is for people who catch everything, recover slowly, or are past 50 and want to shore up an immune system that is winding down as the thymus shrinks. It is the hormone the thymus uses to mature T-cells, and it only works with zinc, so the course is as much about zinc as the peptide. You will not feel it; you judge it by fewer, shorter illnesses over the following months.
The people who reach for it are older adults who get sick often or take weeks to shake a cold, people rebuilding after a long illness or a hard course of treatment, and longevity-minded users who know thymic output falls steeply after middle age. It is the more experimental of the two thymic peptides here; Thymosin Alpha-1 has drug approvals in several countries and is the one to start with if you want the better-studied option. Thymulin is for the person who has run that and wants the other arm, or who wants the specific T-cell maturation effect.
There is nothing to feel on a course, and that is the thing to know up front. No energy lift, no same-day effect, no sign it is working. What good looks like is a winter with fewer infections, or a cold that lasts four days instead of twelve, judged over months. People who run it expecting to feel 'boosted' quit at week two and call it useless, which is the main mistake. The second mistake is running it with low zinc, which makes the whole course pointless.
Our doses are 100 mcg to start, 250 mcg standard and 500 mcg at most, once a day subQ, for 2 to 4 weeks, then a few weeks off before another run. There is little human data on longer runs, so the short course and the gap are caution, not a reset. A 20 mg vial in 3 ml is 6.7 mg/ml, so 250 mcg is 3.8 units on an insulin syringe. Take a normal zinc supplement, 15 to 30 mg a day, through the course, since the hormone is inactive without it. The cost reality is that a 20 mg vial is 80 doses at 250 mcg, a course is 14 to 28, and the mix only keeps about four weeks, so you will throw most of a vial away; buy the smallest vial you can find. Milligram doses, which some vendors suggest to use up the vial, have nothing behind them.
The evidence is older and real on the biology, thin on the use. Thymulin was isolated in the 1970s, its need for zinc was worked out, it was measured for decades as a marker of thymic function and zinc status, and treatment reports in people are few, small and decades old. Modern work is in animals: T-cell maturation, 'normalising' immune responses in both directions, and anti-inflammatory and pain effects with stabilised analogs. There is no contemporary human dosing trial, so the microgram ranges are extrapolated, and it is not an approved medicine anywhere.
Skip it if you have an autoimmune disease, a transplant, or take immune-suppressing drugs; a hormone that reshapes T-cell behaviour is not something to add to those without a specialist. Skip it during active cancer treatment. If you want immune support with a track record, Thymosin Alpha-1 is the answer; if gut inflammation is the real driver of feeling run down, KPV is the cheaper, more direct tool. And if your zinc is low, a zinc supplement alone may do what you were hoping thymulin would.
What people use it for
Maturing T-cells
Some evidenceThymulin pushes immature thymus cells toward functional T-cells and restores thymic markers in animal models of thymic decline, which is its core, well-replicated action. Older human studies measured it as a marker of thymus and zinc status. It is the best-established part of the evidence and still not a treatment trial.
Steadying the immune response
Early daysIn animal work it dampens overactive responses and supports weak ones, which is why it is described as normalising rather than stimulating. The only human data are small, decades-old studies in immune deficiency; nothing modern. In practice this is the 'fewer, shorter illnesses' hope, unproven in current trials.
Inflammation and pain
Early daysStabilised thymulin analogs reduced inflammatory pain and neuroinflammation markers in rodents through cytokine signalling rather than immune cell counts. Interesting as a second line, but the analogs are not what vendors sell, and people with pain have better-evidenced options.
How people use it
Safety, in brief
Things people sometimes notice
- Redness or itching where you inject
- Nothing noticeable, which is expected
- Mild fatigue in the first days for some
The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.
Sources
The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.